Cecilia J Hillard Selected Research

Fatty Acids (Saturated Fatty Acids)

10/2011	Inhibition of fatty acid amide hydrolase suppresses referred hyperalgesia induced by bladder inflammation.
9/2007	Brain uptake and utilization of fatty acids, lipids & lipoproteins: recommendations for future research.
9/2007	Brain uptake and utilization of fatty acids, lipids and lipoproteins: application to neurological disorders.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cecilia J Hillard Research Topics

Disease

15	Inflammation (Inflammations) 04/2024 - 10/2005
14	Pain (Aches) 10/2023 - 10/2011
12	Post-Traumatic Stress Disorders (Post Traumatic Stress Disorder) 11/2023 - 12/2013
8	Parkinson Disease (Parkinson's Disease) 12/2021 - 04/2003
6	Hyperalgesia 03/2024 - 10/2011
6	Alzheimer Disease (Alzheimer's Disease) 01/2023 - 12/2003
5	Neuroinflammatory Diseases 04/2024 - 11/2015
5	Wounds and Injuries (Trauma) 11/2023 - 05/2021
4	Graft vs Host Disease (Graft-Versus-Host Disease) 04/2024 - 01/2021
4	Shock 01/2023 - 01/2017
4	Obesity 01/2020 - 12/2009
4	Neuroblastoma 10/2005 - 04/2003
3	Mental Disorders (Mental Disorder) 11/2023 - 10/2012
3	Substance-Related Disorders (Drug Abuse) 11/2023 - 08/2005
3	Amyloid Plaque 01/2023 - 12/2003
3	Neuralgia (Stump Neuralgia) 11/2022 - 01/2017
3	Cognitive Dysfunction 01/2020 - 03/2005
3	Nervous System Diseases (Neurological Disorders) 01/2017 - 09/2007
3	Mood Disorders (Mood Disorder) 09/2009 - 08/2008
2	Familial cyclic vomiting syndrome 05/2024 - 01/2020
2	Confusion (Bewilderment) 01/2023 - 01/2019
2	Fatigue 08/2022 - 01/2019
2	Chronic Pain 07/2022 - 01/2021
2	Anxiety Disorders (Anxiety Disorder) 05/2022 - 09/2012
2	Traumatic Brain Injuries (Traumatic Brain Injury) 12/2021 - 01/2021
2	Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease) 11/2021 - 01/2021
2	Major Depressive Disorder (Major Depressive Disorders) 01/2021 - 01/2019
2	Autoimmune Diseases (Autoimmune Disease) 10/2020 - 04/2007
2	Neoplasms (Cancer) 10/2020 - 12/2004
2	Spinocerebellar Ataxias (Spinocerebellar Ataxia) 01/2017 - 12/2016
2	Ataxia (Dyssynergia) 01/2017 - 12/2016
2	Cystitis 04/2015 - 10/2011
2	Dyslipidemias (Dyslipidemia) 01/2015 - 12/2009
2	Parkinsonian Disorders (Parkinsonism) 02/2010 - 10/2005
2	Insulin Resistance 12/2009 - 11/2008
2	Multiple Sclerosis 04/2007 - 02/2007
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 04/2007 - 10/2005
1	Autism Spectrum Disorder 11/2023
1	Autistic Disorder (Autism) 11/2023
1	Autonomic Nervous System Diseases (Dysautonomia) 11/2022
1	Leukemia 08/2022
1	Peripheral Nervous System Diseases (PNS Diseases) 01/2022
1	Cushing Syndrome 01/2022
1	Stroke (Strokes) 12/2021

Drug/Important Bio-Agent (IBA)

38	EndocannabinoidsIBA 05/2024 - 12/2003
18	CannabinoidsIBA 01/2023 - 12/2003
13	Cannabinoid Receptors (Cannabinoid Receptor)IBA 04/2024 - 05/2006
11	fatty-acid amide hydrolase (fatty acid amide hydrolase)IBA 11/2022 - 12/2003
8	glyceryl 2-arachidonate (2-arachidonoylglycerol)IBA 11/2023 - 12/2004
7	anandamide (arachidonylethanolamide)IBA 11/2023 - 06/2010
7	CB1 Cannabinoid Receptor (CB1 Receptor)IBA 01/2023 - 12/2004
6	LipidsIBA 01/2021 - 08/2005
5	CytokinesIBA 04/2024 - 11/2015
5	EnzymesIBA 01/2017 - 04/2003
4	Hydrocortisone (Cortisol)FDA LinkGeneric 11/2023 - 12/2013
4	CB2 Cannabinoid ReceptorIBA 10/2023 - 10/2005
4	cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester (URB597)IBA 01/2018 - 10/2011
3	Biomarkers (Surrogate Marker)IBA 01/2024 - 10/2020
3	Amyloid (Amyloid Fibrils)IBA 01/2022 - 11/2015
3	Neuroprotective AgentsIBA 12/2021 - 12/2010
3	CannabidiolIBA 09/2021 - 12/2008
3	LeptinIBA 01/2020 - 01/2015
3	Glutamic Acid (Glutamate)FDA Link 12/2016 - 03/2004
3	Fatty Acids (Saturated Fatty Acids)IBA 10/2011 - 09/2007
3	NeurotoxinsIBA 10/2005 - 04/2003
3	1-Methyl-4-phenylpyridinium (1 Methyl 4 phenylpyridinium)IBA 10/2005 - 04/2003
2	Immune Checkpoint InhibitorsIBA 04/2024 - 08/2023
2	Paclitaxel (Taxol)FDA LinkGeneric 03/2024 - 01/2022
2	Tryptophan (L-Tryptophan)FDA Link 01/2024 - 07/2017
2	CB2 receptor agonist LY2828360IBA 10/2023 - 01/2022
2	Neurotransmitter Agents (Neurotransmitter)IBA 01/2023 - 01/2017
2	tocilizumab (atlizumab)FDA Link 08/2022 - 01/2021
2	enhanced green fluorescent proteinIBA 01/2022 - 05/2018
2	gamma-Aminobutyric Acid (GABA)IBA 01/2021 - 03/2004
2	Glucose (Dextrose)FDA LinkGeneric 12/2016 - 12/2009
2	GlucocorticoidsIBA 01/2015 - 12/2013
2	Insulin (Novolin)FDA Link 01/2015 - 12/2009
2	AntioxidantsIBA 12/2010 - 04/2003
2	RotenoneIBA 02/2010 - 10/2005
2	Messenger RNA (mRNA)IBA 02/2010 - 10/2005
2	alpha-SynucleinIBA 02/2010 - 04/2004
2	Oxidants (Oxidizing Agents)IBA 02/2010 - 04/2004
2	Adenosine (Adenocard)FDA LinkGeneric 12/2008 - 05/2006
2	Lipoproteins (Lipoprotein)IBA 09/2007 - 09/2007
2	IronIBA 04/2004 - 04/2003
1	KynurenineIBA 01/2024
1	CarrageenanIBA 10/2023
1	Amyloid beta-PeptidesIBA 01/2023
1	Cocaine (Cocaine HCl)IBA 01/2023
1	PF 3845IBA 11/2022
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 08/2022
1	OrexinsIBA 05/2022
1	Hormones (Hormone)IBA 01/2022
1	3- (1,1- dimethyl- heptyl)- 1- hydroxy- 9- methoxy- benzo(c)chromen- 6- oneIBA 01/2022

Therapy/Procedure

3	Hematopoietic Stem Cell Transplantation 04/2024 - 01/2021
3	Therapeutics 01/2021 - 07/2017
2	Analgesia 11/2022 - 01/2017
2	Drug Therapy (Chemotherapy) 01/2022 - 01/2017
1	Meditation 05/2024
1	Self Administration (Administration, Self) 01/2023